Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural dexamethasone + ropivacaine vs ropivacaine alone for postoperative pain after VATS lobectomy
ChiCTR2400083032Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain and Persistent postsurgical pain (PPSP) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: PCA consumption of epidural sufentanil 0–24h after surgery. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative painPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2400083032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083032.